Trafficking and Function of Mu-opiod Receptor Genetic Variants
Description: PUBLIC HEALTH RELEVANCE: The use of opioid analgesics to treat pain is highly hampered by variability in patient responses, adverse reactions, and addiction. It is established that genetic factors contribute to this variability, but how they do so is unknown. Understanding how prevalent variations in the mu opioid receptor (MOR), the main target of opioid analgesics, change opioid physiology will broadly improve our understanding of the cellular processes underlying the development of tolerance and dependence to many drugs that are currently abused, and provide a platform for designing better and personalized therapeutic strategies towards combating neuropsychiatric disorders and drug abuse.
Funder: National Institute on Drug Abuse
Funding type: research
Funder scheme: R21
Start date: 2013-09-15
End date: 2015-08-31
Investigator: MANOJKUMAR A PUTHENVEEDU (lead)
Institutions: Carnegie Mellon University, CARNEGIE-MELLON UNIVERSITY
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 15
Funder award ID: R21DA036086
OpenAlex ID: G5962338457
